Laboratory of Molecular Immunology, Rega Institute, KU Leuven, B-3000 Leuven, Belgium.
J Biol Chem. 2010 Sep 24;285(39):29750-9. doi: 10.1074/jbc.M110.119388. Epub 2010 Jul 14.
Posttranslational modifications, e.g. proteolysis, glycosylation, and citrullination regulate chemokine function, affecting leukocyte migration during inflammatory responses. Here, modification of CXCL5/epithelial cell-derived neutrophil-activating protein-78 (ENA-78) by proteases or peptidylarginine deiminases (PAD) was evaluated. Slow CXCL5(1-78) processing by the myeloid cell marker aminopeptidase N/CD13 into CXCL5(2-78) hardly affected its in vitro activity, but slowed down the activation of CXCL5 by the neutrophil protease cathepsin G. PAD, an enzyme with a potentially important function in autoimmune diseases, site-specifically deiminated Arg(9) in CXCL5 to citrulline, generating [Cit(9)]CXCL5(1-78). Compared with CXCL5(1-78), [Cit(9)]CXCL5(1-78) less efficiently induced intracellular calcium signaling, phosphorylation of extracellular signal-regulated kinase, internalization of CXCR2, and in vitro neutrophil chemotaxis. In contrast, conversion of CXCL5 into the previously reported natural isoform CXCL5(8-78) provided at least 3-fold enhanced biological activity in these tests. Citrullination, but not NH(2)-terminal truncation, reduced the capacity of CXCL5 to up-regulate the expression of the integrin α-chain CD11b on neutrophils. Truncation nor citrullination significantly affected the ability of CXCL5 to up-regulate CD11a expression or shedding of CD62L. In line with the in vitro results, CXCL5(8-78) and CXCL5(9-78) induced a more pronounced neutrophil influx in vivo compared with CXCL5(1-78). Administration of 300 pmol of either CXCL5(1-78) or [Cit(9)]CXCL5(1-78) failed to attract neutrophils to the peritoneal cavity. Citrullination of the more potent CXCL5(9-78) lowers its chemotactic potency in vivo and confirms the tempering effect of citrullination in vitro. The highly divergent effects of modifications of CXCL5 on neutrophil influx underline the potential importance of tissue-specific interactions between chemokines and PAD or proteases.
翻译后修饰,如蛋白水解、糖基化和瓜氨酸化,可调节趋化因子功能,影响炎症反应期间白细胞的迁移。在此,评估了蛋白酶或肽基精氨酸脱亚氨酶(PAD)对CXCL5/上皮细胞衍生的中性粒细胞激活蛋白-78(ENA-78)的修饰作用。髓样细胞标志物氨肽酶N/CD13将CXCL5(1-78)缓慢加工成CXCL5(2-78),这几乎不影响其体外活性,但减缓了中性粒细胞蛋白酶组织蛋白酶G对CXCL5的激活作用。PAD是一种在自身免疫性疾病中具有潜在重要功能的酶,它将CXCL5中的精氨酸(Arg(9))位点特异性地脱亚氨生成瓜氨酸,产生[Cit(9)]CXCL5(1-78)。与CXCL5(1-78)相比,[Cit(9)]CXCL5(1-78)诱导细胞内钙信号传导、细胞外信号调节激酶磷酸化、CXCR2内化以及体外中性粒细胞趋化性的效率较低。相反,在这些试验中,将CXCL5转化为先前报道的天然异构体CXCL5(8-78)可使生物活性提高至少3倍。瓜氨酸化而非氨基末端截短降低了CXCL5上调中性粒细胞上整合素α链CD11b表达的能力。截短和瓜氨酸化均未显著影响CXCL5上调CD11a表达或CD62L脱落的能力。与体外结果一致,与CXCL5(1-78)相比,CXCL5(8-78)和CXCL5(9-78)在体内诱导了更明显的中性粒细胞流入。给予300 pmol的CXCL5(1-78)或[Cit(9)]CXCL5(1-78)均未能吸引中性粒细胞进入腹腔。更强效的CXCL5(9-78)的瓜氨酸化降低了其在体内的趋化效力,并证实了瓜氨酸化在体外的调节作用。CXCL5修饰对中性粒细胞流入的高度不同影响强调了趋化因子与PAD或蛋白酶之间组织特异性相互作用的潜在重要性。